Nezkil (400mg) 10 Tablets
Nevirapine 400mg tablets for HIV-1 infection.
Nezkil 400mg contains nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) used as part of combination antiretroviral therapy for HIV-1 infection. Take as directed; usually 400mg once daily after initial lead-in period. Requires monitoring for hepatotoxicity and skin reactions. Pack of 10 tablets.
Purpose
Treatment of HIV-1 infection in combination with other antiretroviral agents.
Ingredients
Nevirapine 400mg per tablet (extended-release) or equivalent.
Warnings
Risk of severe hepatotoxicity and skin reactions. Monitor liver function. Do not use as sole agent. Must be part of combination therapy.
Side Effects
Rash, hepatotoxicity, nausea, headache. Monitor liver function and for severe rash.
Storage Instructions
Store below 25C in a dry place. Protect from moisture.
| Brand | Contineltal |
| Status | Active |
Related Products
